Select Bibliography

Filter by any of these (after searching):

Bashey, Asad

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 4 items

Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Patients with Hematologic Malignancies Who Relapse following Autologous Transplantation: A Multi-Institutional Prospective Study from the Cancer and Leukemia Group B (CALGB trial 100002)

Bashey, Asad , Owzar, Kouros , Johnson, Jeffrey L. ... - - Biol Blood Marrow Transplant - 2011

Manuscript - Primary - Primary - Transplant - CALGB-100002

Updated analysis of CALGB 100104 (Alliance): a randomised phase III study evaluating lenalidomide vs placebo maintenance after single autologous stem cell transplant for multiple myeloma

Holstein, Sarah A. , Jung, Sin-Ho , Richardson, Paul G. ... - - Lancet Haematol - 2017

Manuscript - Primary - Long-Term-Followup - Myeloma - CALGB-100104

Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma

McCarthy, Philip L. , Owzar, Kouros , Hofmeister, Craig C. ... - - N Engl J Med - 2012

Manuscript - Primary - Primary - Myeloma - CALGB-100104

Reduced Intensity Allogeneic Transplantation Provides High Event-Free And Overall Survival In Patients With Advanced Indolent B Cell Malignancies: CALGB 109901

Shea, Thomas , Johnson, Jeffrey , Westervelt, Peter , Farag, Sherif ... - - Biol Blood Marrow Transplant - 2011

Manuscript - Primary - Primary - Transplant - CALGB-109901